derinet® Switzerland
Product names from:
VontobelSVSP
Back

Express VONCERT on AbbVie Inc, Bristol-Myers Squibb, Fresenius & KGaA, Gilead Sciences (Quanto EUR)

  • Valor 46974986
  • ISIN CH0469749862
  • Symbol
sustainable
Bid (indicative)%
Ask (indicative)%
CurrencyEUR
Price on
  • Quanto
  • Barrier observation at the end
  • Autocallable
  • sustainable
AbbVie IncUSD 
Bristol-Myers Squibb Co.USD 
Fresenius SE & Co. KGaAEUR 
Gilead Sciences Inc.USD 
Please note that this is an indication.

Documents

Life cycle
Initial fixing26/03/2019
Payment date02/04/2019
Last trading day28/09/2020
Final fixing28/09/2020
Redemption05/10/2020

Current price information

Intraday1 week1 monthSince emission
until

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
USD 68.32USD 63.61USD 51.68
USD 44.13USD 37.99USD 30.87
EUR 45.63EUR 37.82EUR 30.73
USD 66.92USD 51.30USD 41.68

No chart available

Life cycle
Initial fixing26/03/2019
Payment date02/04/2019
Last trading day28/09/2020
Final fixing28/09/2020
Redemption05/10/2020
Figures
Product typeExpress VONCERT
SSPA categorisationExpress Certificate
Issue price100.00%
Reference currencyEUR
QuantoYes
BarrierUSD 51.68
Barrier observationat the end
Underlying/
ISIN of underlying
AbbVie Inc
US00287Y1091
Spot reference priceUSD 79.51
COSINo
ListingNone
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliveryphysical delivery
Issuance ProgrammeLink to the Issuance Program